Founded in 2019, TAAV Biomanufacturing Solutions is revolutionizing the biotechnology and manufacturing industries with its novel approach to gene therapy. The company's slogan, "TAAV is offering neDNA™: an enzymatic, linear, double stranded DNA as the new standard for AAV production," encapsulates its mission. By introducing neDNA™ as the industry standard for transfection-based AAV production, TAAV aims to provide a safer, more effective, scalable, and faster method for AAV manufacturing. With its cutting-edge technology and innovative solutions, TAAV Biomanufacturing Solutions is poised to make a significant impact in the biotechnology and manufacturing sectors.
There is no investment information
No recent news or press coverage available for TAAV Biomanufacturing Solutions.